James Rolke Revelation Biosciences, Inc. (REVB) insider trading activity

REVB Quotes by TradingView

James Rolke is Chief Executive Officer of REVELATION BIOSCIENCES, INC.. Currently has a direct ownership of 933,489 shares of REVB, which is worth approximately $840,140. The most recent transaction as insider was on Jan 08, 2026, when has been sold 532,829 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $479,546. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 933K
2997.48% 3M change
n/a 12M change
Total Value Held $840,140

James Rolke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2026
BUY
Grant, award, or other acquisition
$479,546 $0.9 p/Share
532,829 Added 36.34%
933,489 Common Stock
Oct 29 2025
BUY
Grant, award, or other acquisition
$499,985 $1.28 p/Share
390,614 Added 49.37%
400,660 Common Stock
Feb 11 2025
BUY
Grant, award, or other acquisition
$116,467 $3.87 p/Share
30,095 Added 49.97%
30,137 Common Stock
JR

James Rolke

Chief Executive Officer
San Diego, CA

Track Institutional and Insider Activities on REVB

Follow REVELATION BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REVB shares.

Notify only if

Insider Trading

Get notified when an Revelation Biosciences, Inc. insider buys or sells REVB shares.

Notify only if

News

Receive news related to REVELATION BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REVB